IL18BP and sarcopenia: We undertook a two-stage investigation, firstly using a proteomics-based approach to identify inflammatory mediators that increased in a cohort of patients undergoing aortic surgery, and secondly undertaking detailed cross-sectional and longitudinal studies in two contrasting populations – an expanded cohort of acute sarcopenia patients and another with chronic sarcopenia of a promising candidate inflammatory marker – IL-18BP.